
The highly affluent Lundbeck Foundation turns up its level of ambition and gets ready to place some of the fund's fortune in worthy companies.
In the next couple of years, the foundation will acquire massive owner's shares in up to five more companies, so the portfolio will no longer "just" consist of a controlling owner's share in the pharmaceutical companies Lundbeck and ALK and the Danish safety and healthcare company Falck.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app